Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality from cardiovascular disease in women with breast cancer - a nationwide registry study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of human papillomavirus in sinonasal cancer-a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  1. Examination of hearing loss among school-aged children in Greenland

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of human papillomavirus in sinonasal cancer-a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Systemic Immune Profile in Patients With CRSwNP

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: The increasing incidence of oral cavity squamous cell carcinoma (OSCC) is challenging the capacity to treat patients efficiently. The aim of this study was to evaluate the impact of time to treatment initiation (TTI) on overall survival (OS) and recurrence free survival (RFS) for patients with primary OSCC. Material and methods: All patients with primary OSCC treated with curative intent at Rigshospitalet in the period 2000–2014 with known date of diagnosis and treatment initiation were included. Correlation analyses between TTI and Charlson comorbidity index (CCI), UICC stage, and year of diagnosis were performed in addition to uni- and multivariate Cox proportional hazard regression analyses. Further, interaction analysis of TTI and UICC stage were conducted. Results: Eight hundred and sixty-two patients (64% men) with a median age at diagnosis of 62 years (range: 28–95 years) were included. The median TTI was 31 days (range: 2–137 days). Correlation analyses showed correlations between TTI and CCI, TTI and UICC stage, and TTI and year of diagnosis (rho = −0.10, p-value = <.01; rho = 0.16, p-value = <.001; rho = −0.47 p-value = <.001). Univariate analyses showed a statistically significant increase in hazard ratio for both OS and RFS with a five-day increase in TTI (HR = 1.05, 95%CI: 1.02–1.07 and HR = 1.04, 95%CI: 1.02–1.07). However, when adjusting for age, sex, smoking, UICC stage, tumor sublocation, CCI, and year of diagnosis in a multivariate analysis, the increase in HR with TTI was not statistically significant. There was no statistically significant interaction between TTI and UICC stage. Conclusion: Survival of OSCC patients decreased with increasing TTI, yet not statistically significant in multivariate analysis. There was no difference in the effect of TTI between patients diagnosed in low or advanced stages.

Original languageEnglish
JournalActa Oncologica
Volume60
Issue number4
Pages (from-to)491-496
Number of pages6
ISSN0284-186X
DOIs
Publication statusPublished - Apr 2021

Bibliographical note

Publisher Copyright:
© 2020 Acta Oncologica Foundation.

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

    Research areas

  • OSCC, time to treatment initiation, treatment delay, survival, recurrence

ID: 61785700